中国脑血管病临床管理指南(第2版)(节选)——第3章 脑血管病高危人群管理 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Except) ——Chapter Three Management of Patients at Hige-risk of Cerebrovascular Diseases
针对脑血管病的危险因素积极进行早期干预管理是减少脑血管病危害最有效的方法。本章节介绍脑血管病高危人群管理的推荐意见,包括对不可干预和可干预血管危险因素的控制,阿司匹林在缺血性卒中一级预防中的应用以及首次卒中风险评估等方面。 Abstract: Early intervention to manage the risk factors of cerebrovascular disease is the most effective way to reduce the harm of cerebrovascular diseases. This chapter presents recomm...
Main Author: | |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Chinese Journal of Stroke
2023-08-01
|
Series: | Zhongguo cuzhong zazhi |
Subjects: | |
Online Access: | http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=3860 |
_version_ | 1827821030061637632 |
---|---|
author | 王伊龙,陈玮琪,刘欣如,王文志,王永刚,王婷婷,王蓬莲,刘改芬,江滨,许予明,许玉园,许杰,孙冬玲,孙海欣,李子孝,李姝雅,杨沫,杨晓萌,杨营营,周梦圆,郑华光,宗黎霞,单舒乙,赵璟妍,茹小娟,姜勇,秦海强,贾茜,高远,梅延亮,曹勇,盖思齐,焦玉明,谢雪微,潘岳松,中国卒中学会中国脑血管病临床管理指南撰写工作委员会 |
author_facet | 王伊龙,陈玮琪,刘欣如,王文志,王永刚,王婷婷,王蓬莲,刘改芬,江滨,许予明,许玉园,许杰,孙冬玲,孙海欣,李子孝,李姝雅,杨沫,杨晓萌,杨营营,周梦圆,郑华光,宗黎霞,单舒乙,赵璟妍,茹小娟,姜勇,秦海强,贾茜,高远,梅延亮,曹勇,盖思齐,焦玉明,谢雪微,潘岳松,中国卒中学会中国脑血管病临床管理指南撰写工作委员会 |
author_sort | 王伊龙,陈玮琪,刘欣如,王文志,王永刚,王婷婷,王蓬莲,刘改芬,江滨,许予明,许玉园,许杰,孙冬玲,孙海欣,李子孝,李姝雅,杨沫,杨晓萌,杨营营,周梦圆,郑华光,宗黎霞,单舒乙,赵璟妍,茹小娟,姜勇,秦海强,贾茜,高远,梅延亮,曹勇,盖思齐,焦玉明,谢雪微,潘岳松,中国卒中学会中国脑血管病临床管理指南撰写工作委员会 |
collection | DOAJ |
description | 针对脑血管病的危险因素积极进行早期干预管理是减少脑血管病危害最有效的方法。本章节介绍脑血管病高危人群管理的推荐意见,包括对不可干预和可干预血管危险因素的控制,阿司匹林在缺血性卒中一级预防中的应用以及首次卒中风险评估等方面。
Abstract: Early intervention to manage the risk factors of cerebrovascular disease is the most effective way to reduce the harm of cerebrovascular diseases. This chapter presents recommendations for the management of populations at high risk for cerebrovascular disease, including control of non-interventionable and interventionable vascular risk factors, the use of aspirin in the primary prevention of ischaemic stroke, and the risk assessment of first-time stroke. |
first_indexed | 2024-03-12T01:37:39Z |
format | Article |
id | doaj.art-ddd0c652f4da4b0facc3232ccb99926a |
institution | Directory Open Access Journal |
issn | 1673-5765 |
language | zho |
last_indexed | 2024-03-12T01:37:39Z |
publishDate | 2023-08-01 |
publisher | Editorial Department of Chinese Journal of Stroke |
record_format | Article |
series | Zhongguo cuzhong zazhi |
spelling | doaj.art-ddd0c652f4da4b0facc3232ccb99926a2023-09-11T06:21:03ZzhoEditorial Department of Chinese Journal of StrokeZhongguo cuzhong zazhi1673-57652023-08-0118889890910.3969/j.issn.1673-5765.2023.08.008中国脑血管病临床管理指南(第2版)(节选)——第3章 脑血管病高危人群管理 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Except) ——Chapter Three Management of Patients at Hige-risk of Cerebrovascular Diseases王伊龙,陈玮琪,刘欣如,王文志,王永刚,王婷婷,王蓬莲,刘改芬,江滨,许予明,许玉园,许杰,孙冬玲,孙海欣,李子孝,李姝雅,杨沫,杨晓萌,杨营营,周梦圆,郑华光,宗黎霞,单舒乙,赵璟妍,茹小娟,姜勇,秦海强,贾茜,高远,梅延亮,曹勇,盖思齐,焦玉明,谢雪微,潘岳松,中国卒中学会中国脑血管病临床管理指南撰写工作委员会0王伊龙 yilong528@gmail.com针对脑血管病的危险因素积极进行早期干预管理是减少脑血管病危害最有效的方法。本章节介绍脑血管病高危人群管理的推荐意见,包括对不可干预和可干预血管危险因素的控制,阿司匹林在缺血性卒中一级预防中的应用以及首次卒中风险评估等方面。 Abstract: Early intervention to manage the risk factors of cerebrovascular disease is the most effective way to reduce the harm of cerebrovascular diseases. This chapter presents recommendations for the management of populations at high risk for cerebrovascular disease, including control of non-interventionable and interventionable vascular risk factors, the use of aspirin in the primary prevention of ischaemic stroke, and the risk assessment of first-time stroke.http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=3860脑血管病危险因素高血压糖代谢脂代谢心房颤动动脉粥样硬化cerebrovascular diseaserisk factorhypertensionglycometabolismlipid metabolismatrial fibrillationatherosclerosis |
spellingShingle | 王伊龙,陈玮琪,刘欣如,王文志,王永刚,王婷婷,王蓬莲,刘改芬,江滨,许予明,许玉园,许杰,孙冬玲,孙海欣,李子孝,李姝雅,杨沫,杨晓萌,杨营营,周梦圆,郑华光,宗黎霞,单舒乙,赵璟妍,茹小娟,姜勇,秦海强,贾茜,高远,梅延亮,曹勇,盖思齐,焦玉明,谢雪微,潘岳松,中国卒中学会中国脑血管病临床管理指南撰写工作委员会 中国脑血管病临床管理指南(第2版)(节选)——第3章 脑血管病高危人群管理 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Except) ——Chapter Three Management of Patients at Hige-risk of Cerebrovascular Diseases Zhongguo cuzhong zazhi 脑血管病 危险因素 高血压 糖代谢 脂代谢 心房颤动 动脉粥样硬化 cerebrovascular disease risk factor hypertension glycometabolism lipid metabolism atrial fibrillation atherosclerosis |
title | 中国脑血管病临床管理指南(第2版)(节选)——第3章 脑血管病高危人群管理 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Except) ——Chapter Three Management of Patients at Hige-risk of Cerebrovascular Diseases |
title_full | 中国脑血管病临床管理指南(第2版)(节选)——第3章 脑血管病高危人群管理 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Except) ——Chapter Three Management of Patients at Hige-risk of Cerebrovascular Diseases |
title_fullStr | 中国脑血管病临床管理指南(第2版)(节选)——第3章 脑血管病高危人群管理 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Except) ——Chapter Three Management of Patients at Hige-risk of Cerebrovascular Diseases |
title_full_unstemmed | 中国脑血管病临床管理指南(第2版)(节选)——第3章 脑血管病高危人群管理 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Except) ——Chapter Three Management of Patients at Hige-risk of Cerebrovascular Diseases |
title_short | 中国脑血管病临床管理指南(第2版)(节选)——第3章 脑血管病高危人群管理 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Except) ——Chapter Three Management of Patients at Hige-risk of Cerebrovascular Diseases |
title_sort | 中国脑血管病临床管理指南 第2版 节选 第3章 脑血管病高危人群管理 chinese stroke association guidelines for clinical management of cerebrovascular diseases second edition except chapter three management of patients at hige risk of cerebrovascular diseases |
topic | 脑血管病 危险因素 高血压 糖代谢 脂代谢 心房颤动 动脉粥样硬化 cerebrovascular disease risk factor hypertension glycometabolism lipid metabolism atrial fibrillation atherosclerosis |
url | http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=3860 |
work_keys_str_mv | AT wángyīlóngchénwěiqíliúxīnrúwángwénzhìwángyǒnggāngwángtíngtíngwángpéngliánliúgǎifēnjiāngbīnxǔyǔmíngxǔyùyuánxǔjiésūndōnglíngsūnhǎixīnlǐzixiàolǐshūyǎyángmòyángxiǎoméngyángyíngyíngzhōumèngyuánzhènghuáguāngzōnglíxiádānshūyǐzhàojǐngyánrúxiǎojuānjiāngyǒngqínhǎiq zhōngguónǎoxuèguǎnbìnglínchuángguǎnlǐzhǐnándì2bǎnjiéxuǎndì3zhāngnǎoxuèguǎnbìnggāowēirénqúnguǎnlǐchinesestrokeassociationguidelinesforclinicalmanagementofcerebrovasculardiseasessecondeditionexceptchapterthreemanagementofpatientsathigeriskofcerebrovasculard |